Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Outpatient Surgical Quality and Access Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Food and Drug Administration Regulatory Issues
Improving Seniors’ Timely Access to Care Act of 2019
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · third_quarter · Q3
Trade Issues/Policy
Tax Issues;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Improving Seniors’ Timely Access to Care Act of 2019
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Improving Seniors’ Timely Access to Care Act of 2019
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Improving Seniors’ Timely Access to Care Act of 2019
Client: ZIMMER BIOMET, INC. · Firm: ZIMMER BIOMET, INC.
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Medical Device tax Repeal (S. 692), Corporate Tax
Medical Device tax Repeal (S. 692), FDARA Implementation
2026 · second_quarter · Q2
Tax Issues; Medical Device Tax repeal
Trade Issues/Policy
Tariff policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2026 · first_quarter · Q1
Trade Issues/Policy, Tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · fourth_quarter · Q4
Trade Issues/Policy, Tariffs
Federal Government Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · third_quarter · Q3
Trade Issues/Policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · second_quarter · Q2
Trade Issues/Policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2025 · first_quarter · Q1
Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Equality in Medicaid and Medicare Treatment Act
Trade Issues
Outpatient Surgical Quality and Access Act
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · fourth_quarter · Q4
Trade related policy;
Medicare Coverage of Innovative Medical Devices; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Artificial Intelligence and Machine Learning regulation and Medicare payment; Equality in Medicaid and Medicare Treatment Act
ASC copay cap; Outpatient Surgical Quality and Access Act
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · third_quarter · Q3
Tax Issues; R&D tax policy
Trade related policy;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · second_quarter · Q2
Trade related policy;
Tax Issues; R&D tax policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2024 · first_quarter · Q1
Trade related policy;
Tax Issues; R&D tax policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · fourth_quarter · Q4
Trade related policy;
Tax Issues; R&D tax policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · third_quarter · Q3
Trade Issues
Equality in Medicaid and Medicare Treatment Act; Medicare and Medicaid Treatment (EMMT) Act; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment
Pandemic All Hazards Preparedness Act
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · second_quarter · Q2
Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment;Equality in Medicaid and Medicare Treatment Act
Pandemic All Hazards Preparedness Act; Outpatient Surgical Quality and Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2023 · first_quarter · Q1
Food and Drug Administration Regulatory Issues
Trade Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · fourth_quarter · Q4
PREVENT Pandemics Act
Consolidated Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · third_quarter · Q3
Data security; Medical Device User Fee Authorization
Extending Government Funding and Delivering Emergency Assistance Act
Equality in Medicare and Medicaid Treatment Act; Medicare Physician Payment; ASC/OPPS Medicare Payment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · second_quarter · 2A
MDUFA V, shortage reporting, FDARA bill, PREVENT Act, Outpatient Surgery Quality and Access Act, oEquality in Medicare and Medicaid Treatment Act, Medical Device User Fee Authorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · second_quarter · Q2
MDUFA V, shortage reporting, FDARA bill, PREVENT Act, Outpatient Surgery Quality and Access Act, oEquality in Medicare and Medicaid Treatment Act, Medical Device User Fee Authorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2022 · first_quarter · Q1
MDUFA V, shortage reporting, FDARA bill, PREVENT Act, Outpatient Surgery Quality and Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · fourth_quarter · Q4
Patient access to ambulatory surgery centers; Addressing health disparities, Medicare Outpatient Surgery and Quality Access Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · third_quarter · Q3
Medical device supply chain and shortages;
Health equity and access
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · second_quarter · Q2
Device shortage reporting requirements
FDA CFG Authentication Issue; Processing delay at US State Department; Equitable access to medical technology; Device shortage reporting requirements
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2021 · first_quarter · Q1
COVID vaccine allocation and funding; Equitable access to medical technology
FDA CFG Authentication Issue; Processing delay at US State Department
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · second_quarter · 2A
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
CARES Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · fourth_quarter · Q4
CARES Act; Consolidated Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · second_quarter · 2A
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
CARES Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · third_quarter · Q3
CARES Act
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · second_quarter · Q2
Federal COVID stimulus packages especially CARES 2.0 and 3.0; HR 3107
CARES Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2020 · first_quarter · Q1
CARES Act, Device shortage reporting during a public health emergency, Paycheck Protection Act,
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · fourth_quarter · Q4
Medical Device Tax Repeal, Corporate Tax
Medical Device tax Repeal (S. 692), Corporate Tax
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · third_quarter · Q3
Medical Device tax Repeal (S. 692), FDARA Implementation
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, U.S. Trade Representative (USTR)
ZIMMER BIOMET, INC. via ZIMMER BIOMET, INC.
2019 · third_quarter · RA
MDET repeal, FDA Regulations, VA Procurement
MDET repeal, FDA Regulations, VA Procurement
MDET repeal, FDA Regulations, VA Procurement
Pandemic All Hazards Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pandemic All Hazards Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Outpatient Surgical Quality and Access Act; H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Food and Drug Administration Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MDET repeal, FDA Regulations, VA Procurement